OMICS International Organises 3000+ Global Conferenceseries Events Every Year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open access journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
For more Conferences visit


Arvind Chhabra

Arvind Chhabra

Assistant Professor
Department Of Medicine
University of Connecticut Health Center
Tel: 860-679-1447
Fax: 860-679-1154


Arvind Chhabra is an Assistant Professor at Department of Medicine and Stem Cell Institute of University of Connecticut Health Center. He has completed his postdoctoral research in 2007 from Department of Medicine, University of Connecticut Health Center before which he attained his doctoral degree from Department of Microbiology of Central Drug Research Institute (CDRI) located at Lucknow, India in 2001.


His research work is aimed at developing an effective immune based cancer therapy. Since most human tumor antigens are “self-antigens” and most human tumors are MHC class I positive, but MHC class II negative the generation of a potent anti-tumor immune response faces many inherent constraints. Among these include and extremely low precursor frequency of an ti-tumor T cells in tumor immunity, expecially in an antigen specific manner. They have developed multiple approach to effectively address these limitations, utilizing the human melanoma associated antigens as model tumor antigens. He have published his findings in prominent peer-review journal and research work has earned him several awards at international cancer immunotherapy meetings. In addition to his work on human melanoma, ongoing research efforts in his laboratory are aimed at extending his expertise to the human breast cancer model and also to utilize the human pluripotent stem cells [hps, i.e.. human embryonic stem cells (hES) and induced pluripotent stem cells (iPS)] for developing patient specific cancer immunotherapy approaches through TCR engineering approach.